✦ LIBER ✦

Does local treatment affect the outcome of breast cancer?— An alternative view of the Manchester regional breast study

✍ Scribed by L. E. Hughes; D. J. T. Webster; H. S. Shukla; H. Cambell; J. P. Lythgoe; M. K. Palmer

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 328 KB
Volume: 70
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800700626

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An exploratory instrumental variable ana

An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population

✍ Jack Hadley; Daniel Polsky; Jeanne S. Mandelblatt; Jean M. Mitchell; Jane C. Wee 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract This study is motivated by the potential problem of using observational data to draw inferences about treatment outcomes when experimental data are not available. We compare two statistical approaches, ordinary least‐squares (OLS) and instrumental variables (IV) regression analysis, to

Conservation surgery and irradiation as

Conservation surgery and irradiation as an alternative to mastectomy in the treatment of clinically favorable breast cancer

✍ Eleanor D. Montague; Frederick C. Ames; Sylvia R. Schell; Marvin M. Romsdahl 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 2 views

Does the increase of endogenous steroid

Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case–control study in Chongqing, China

✍ Bin Wang; Mantian Mi; Jian Wang; Na Wei; Qianyong Zhang; Jundong Zhu; Shu Yang; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 1 views

## Abstract Accumulating epidemiological evidence suggests that sex steroid hormones are positively associated with the development of breast cancer. However, most of these studies were conducted among Caucasian women and few have been carried out in China. To determine whether the associations of

Phase 3 study comparing the use of docet

Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer

✍ Edgardo Rivera; Jaime A. Mejia; Banu K. Arun; Rosnie B. Adinin; Ronald S. Walter 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

## Abstract ## BACKGROUND Previous studies have evaluated 3‐week and weekly docetaxel schedules in patients with metastatic breast cancer (MBC). The varying efficacy results and toxicity profiles noted in these earlier studies led to a comparison of the schedules to determine which was safer and m